FindTrial
Sign In

Seroprevalence of antibodies against various vaccine preventable diseases among the rural population of Maharashtra

A cross-sectional study to assess levels of antibodies against Pentavalent, Measles-Rubella vaccine and Respiratory Syncytial Virus among the rural population of Maharashtra - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/07/090122
Enrollment
900
Registered
2025-07-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil

Sponsors

Bharati Vidyapeeth DU Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Any child between 1 and 17 years of age and an adult residing in the study area

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Anti-Measles antibodies in children aged 1-17 years and adults residing in rural areasTimepoint: Cross-sectional study, so it will be assessed at baseline (single visit)—

Secondary

MeasureTime frame
seroprevalence of antibodies against diphtheria, pertussis, tetanus, Hib, hepatitis B, rubella & RSV in children aged 1-15 yearsTimepoint: Cross-sectional study, so it will be assessed at the baseline visit—

Countries

India

Contacts

Public ContactDr Sonali Palkar

Bharati Vidyapeeth DU Medical College Pune

palkarsh@gmail.com9881008717

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026